⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

MRNA

Moderna, Inc.

Healthcare · Biotechnology

200.10USD

-2.5300 (-1.25%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on MRNA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 200.10
P/E—
Dvd Ind Yld0.0%
P/B11.82
P/S35.9
Curr EV/T12M EBITDA-34.6
Mkt Cap (USD)79.9B
Curr EV (USD)76.0B
2)

Per Share Data

EPS T12M-8.00
DPS—
Bk Val Per Sh16.95
Rev/Sh5.60
Cash/Sh12.87
Curr Shares Out399.2M
FCF/Sh-3.13
3)

Cash Flow Analysis

P/CF-74.5
Curr P/FCF-64.2
CF/NI0.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-48.2%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr21.8%
Cap 1Y Gr-15.2%
BPS 1Y Gr-21.7%
R&D To Sales129.1%
Retention Rate100.0%
Rev 1Y Gr-39.9%
FCF 1Y Gr49.1%
Assets 1Y Gr-12.8%
5)

Profitability

EBITDA-3.1B
EBIT-3.3B
Operating Margin-149.0%
Pretax Margin-138.6%
Net Margin-141.4%
ROA-27.4%
ROE-39.0%
ROC—
Asset Turnover0.19
6)

Structure

Current Ratio2.29
Quick Ratio2.07
Debt/Assets11.7%
Debt/Com Eq19.0%
Net Debt/EBITDA0.14
Tot Debt/Capital16.0%
Gross Margin23.4%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.